Stock ALSEN SENSORION
Add to a list
To use this feature you must be a member
Log inSign up

News Sensorion

Equities

ALSEN

FR0012596468

Real-time Euronext Paris
Other stock markets
 06:44:05 2024-04-25 am EDT 		5-day change 1st Jan Change
0.71 EUR +2.90% Intraday chart for Sensorion -3.01% +65.12%
Apr. 08 Sensorion: completion of a private placement CF
Apr. 05 Sensorion SA announced that it expects to receive ?15 million in funding CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sensorion : Inside Information / Other news releases
PU
Sensorion Announces its Participation in the Van Lanschot Kempen's Life Sciences Conference
BU
Sensorion: completion of a private placement
CF
Sensorion Announces a €15 Million Financing, Extending Cash Runway Until the End of 2025
BU
Sensorion SA announced that it expects to receive ?15 million in funding
CI
Sensorion Announces the Availability of Its Letter to Shareholders
BU
Sensorion Announces its Participation in the Annual Bioprocessing Summit Europe
BU
Sensorion : Annual financial and audit reports / Terms of availability of the annual financial report
PU
Sensorion Announces the Availability of its Financial Report for 2023
BU
Sensorion Reports Full-Year 2023 Financial Results and Business Update
BU
Sensorion: study results in hearing loss
CF
Sensorion Announces it Has Met Primary Endpoint for SENS-401 Phase 2a Clinical Study for Residual Hearing Preservation
BU
Sensorion Meets Primary Endpoint for Sens-401 Phase 2A Clinical Study for Residual Hearing Preservation
CI
Sensorion : Inside Information / Other news releases
PU
Sensorion Will Host a Webcast on March 14, 2024, to Announce its 2023 Annual Financial Results
BU
Sensorion Announces its Participation in the Leerink Partners Global Biopharma Conference
AQ
Sensorion SA Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Sensorion Announces a EUR50.5 Million Financing with Participation from New and Existing US and European Healthcare Specialist Investors
AQ
Sensorion: completion of private placement
CF
Sensorion Announces the Completion of Patient Inclusion in Phase 2A Clinical Trial of Sens-401 for Residual Hearing Preservation After Cochlear Implantation
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALSEN Stock
  4. News Sensorion